FDA Approves Unknown Drug — GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd. received Abbreviated New Drug Application (ANDA) approval on May 4, 2012, clearing the company to produce and market the generic version of the relevant drug substance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day